undamentalytics Newsletter

Nano Labs Ltd (NA) stock

Add holding +

NASDAQ: NA Nasdaq Semiconductors

Nano Labs Ltd is a US-listed company in the semiconductors industry. Its financial year ends in December.

Stock price today

Loading chart…

Third-party market data · may be delayed

Model estimate per share

Not valued: the figures our models need are missing or failed our data-quality checks.

Price vs value

No model value: reported crypto treasury NAV excludes the operating business. How we value companies.

Who’s trading

What company insiders, investment funds and members of Congress have been doing with the stock, from their own filings.

  • Insiders0 buying, 1 selling0 purchases and 91 sales by directors and officers, last 12 monthsInsider trades
  • Funds8 adding, 3 cuttingOf 0 active managers that changed their stake, 0 added; quarter to June 30, 2026Fund buyers and sellers

Value diary

Our note on each quarter Nano Labs files

Where Nano Labs stands after its latest Filing

Nano Labs has little or no product revenue yet; it used $15m of cash in the twelve months. The diluted share count is up 146.7% on a year earlier, which dilutes existing holders. It passes 3 of our 6 financial-health checks.

Our models give no value for Nano Labs at present, so past values are not shown.

Written from the company's filings and our models when each quarter's report arrives. Figures in older notes are as published at the time. Not investment advice.

The Fundamentalytics view

Nano Labs Ltd's trailing-twelve-month revenue fell 33.4% year on year, with a free-cash-flow margin of -401.1%.

Current signal Net margin expanding: TTM net margin reached 501.6%, up 780.4pp year over year.

Assembled from SEC-filed figures — the full workings are on this page and in our methodology. Observations, not recommendations.

Strengths

  • High operating margin. 264.4% of revenue is left as operating profit.
  • Margins widening. Operating margin is up 545.8 points on a year ago.

Things to watch

  • Revenue shrinking. Revenue fell 33.4% over the last 12 months.
  • Burning cash. Free cash flow was -401.1% of revenue over the last 12 months.
  • Share dilution. Diluted shares rose 146.7% in a year.
  • High debt. Long-term debt exceeds cash by $0.0bn, more than 1.5 times annual revenue.
  • Gross margin slipping. Gross margin is down 175.9 points on a year ago.
  • Weak cash conversion. Free cash flow was -80% of net income over the last 12 months.

Price chart

  • 1 day+1.3%
  • 1 week-7.9%

Closing prices to 2026-11-02. Price change only, dividends excluded.

Loading chart…

Third-party market data · may be delayed

At a glance

Trailing twelve months, from SEC filings

Profitability

Revenue (TTM)
$3.8M
Operating margin
264.4%
Net margin
501.6%
EPS (TTM, diluted)
$0.95

Growth

Revenue growth
−33.4%
Change in growth rate
+15.6 pts
Share count change
+146.7%

Cash

Free cash flow (TTM)
-$15.1M
FCF margin
-401.1%
Stock pay % of revenue
0.3%

News & updates

Updated November 2, 2026

Company announcements, filed results and changes that matter to shareholders.

No recent updates are available for NA from the sources we follow. See filings →

Refreshed hourly when new source data is available. Summaries are checked against company releases and SEC filings. Company announcement headlines are labelled when a checked summary is unavailable.

Reported holdings, with the date attached

Crypto treasury position

Balance date: not reconciled

Net treasury position / share—

This measures the reported treasury after the equity-bridge claims. It excludes the operating business, mining equipment and other assets, and is not updated for crypto price moves or purchases since the filing. A treasury deficit does not mean the whole company has negative equity value.

Crypto holdings are stale (reported 2025-12-31); no current position is assumed.

Fundamentalytics rating

model v1.6 · 2026-11-03

Not rated: reported crypto treasury NAV excludes the operating business.

Valuation models

We value Nano Labs Ltd as a crypto treasury or miner, with every model that fits that kind of business. Cost of equity 14%: the 10-year Treasury yield (4.9%) plus a beta of 2.11 times a 4.5% equity risk premium.

Value per share by model
Model Value per share In the combined value?
Reported crypto treasury NAV Reported crypto holdings at fair value plus cash and short-term investments, less debt, preferred stock and other claims, per listed share. Dated to the filing; excludes the operating business and future token purchases. Not a live crypto NAV. — Does not apply: Crypto holdings are stale (reported 2025-12-31); no current position is assumed.
Combined value Reported crypto treasury NAV only, not a valuation of the operating business. No growth, price premium or future crypto purchases are assumed. — No model applies: the filings don’t yet support a value.

Different models fail in different ways, so where several apply we average them rather than trust one. Peer-based models compare Nano Labs Ltd with crypto treasuries and miners in our coverage, using third-party market data. Model values are estimates under stated assumptions, updated as new filings arrive; not price targets or investment advice. How each model works.

Moat

Not assessed: fewer than five years of comparable figures in the filings. AI disruption exposure for this industry: Low.

A rules-based reading of reported figures, not a forecast and not investment advice. How the score is built: methodology.

Forecasts and guidance

Analysts' consensus

No analyst estimates are published for Nano Labs Ltd: too few analysts cover it.

Positioning

Short interest
7.9%
of tradable shares
Days to cover
30.81
at average volume
Short interest, 1 month
−2%
to October 15, 2026
Held by institutions
43%
of shares
Held by insiders
56.0%
of shares
Employees
67
full time

Consensus figures average analysts' published estimates (third-party data); guidance is the company's own. Neither is our forecast. Short interest is reported twice a month and lags. Market data may be delayed.

This section is general information, not investment advice or a personal recommendation, and it does not take account of your objectives or circumstances. Forecasts and guidance are estimates, not promises: companies miss their own guidance and analysts' figures are often revised. Prices can fall as well as rise, and you can lose money. See our disclaimer.

Share-price performance

Market data may be delayed

Recent prices are available. Older price history and the statistics that need it are being loaded in the background.

Price behaviour

52-week range
Not enough history
From 52-week high
—
vs 50-day average
—
vs 200-day average
—
Volatility (1 year)
—
Beta vs S&P 500
—

Volatility is the annualised standard deviation of daily returns. Beta 1.5 means the shares typically moved 1.5% for each 1% move in the S&P 500 over the past year. Prices to November 2, 2026.

Fundamentals

Revenue (TTM) Nano Labs Ltd
$0 $50M $100M $150M FY20 Q4 FY21 Q4 FY22 Q4 FY23 Q4 FY24 Q4 FY25 Q4 Revenue (TTM), FY20 Q4: $308.2K Revenue (TTM), FY21 Q4: $6.1M Revenue (TTM), FY22 Q4: $146.4M Revenue (TTM), FY23 Q4: $11.1M Revenue (TTM), FY24 Q4: $5.6M Revenue (TTM), FY25 Q4: $3.8M $3.8M

Source: SEC EDGAR filings. Retrieved Invalid Date.

View chart data
Period Revenue (TTM)
FY20 Q4 $308.2K
FY21 Q4 $6.1M
FY22 Q4 $146.4M
FY23 Q4 $11.1M
FY24 Q4 $5.6M
FY25 Q4 $3.8M
Revenue growth, TTM YoY Nano Labs Ltd
-1000% 0% 1000% 2000% 3000% FY21 Q4 FY22 Q4 FY23 Q4 FY24 Q4 FY25 Q4 Revenue growth, TTM YoY, FY21 Q4: 1883.6% Revenue growth, TTM YoY, FY22 Q4: 2294.4% Revenue growth, TTM YoY, FY23 Q4: -92.4% Revenue growth, TTM YoY, FY24 Q4: -49.0% Revenue growth, TTM YoY, FY25 Q4: -33.4% -33.4%

Source: SEC EDGAR filings. Retrieved Invalid Date.

View chart data
Period Revenue growth, TTM YoY
FY21 Q4 1883.6%
FY22 Q4 2294.4%
FY23 Q4 -92.4%
FY24 Q4 -49.0%
FY25 Q4 -33.4%
Operating margin (TTM) Nano Labs Ltd
-2000% -1000% 0% 1000% FY20 Q4 FY21 Q4 FY22 Q4 FY23 Q4 FY24 Q4 FY25 Q4 Operating margin (TTM), FY20 Q4: -1735.9% Operating margin (TTM), FY21 Q4: -453.3% Operating margin (TTM), FY22 Q4: 2.1% Operating margin (TTM), FY23 Q4: -332.9% Operating margin (TTM), FY24 Q4: -281.4% Operating margin (TTM), FY25 Q4: 264.4% 264.4%

Source: SEC EDGAR filings. Retrieved Invalid Date.

View chart data
Period Operating margin (TTM)
FY20 Q4 -1735.9%
FY21 Q4 -453.3%
FY22 Q4 2.1%
FY23 Q4 -332.9%
FY24 Q4 -281.4%
FY25 Q4 264.4%
FCF margin (TTM) Nano Labs Ltd
-600% -400% -200% 0% 200% FY20 Q4 FY21 Q4 FY22 Q4 FY23 Q4 FY24 Q4 FY25 Q4 FCF margin (TTM), FY20 Q4: -186.4% FCF margin (TTM), FY21 Q4: 159.8% FCF margin (TTM), FY22 Q4: -29.7% FCF margin (TTM), FY23 Q4: -305.0% FCF margin (TTM), FY24 Q4: -432.8% FCF margin (TTM), FY25 Q4: -401.1% -401.1%

Source: SEC EDGAR filings. Retrieved Invalid Date.

View chart data
Period FCF margin (TTM)
FY20 Q4 -186.4%
FY21 Q4 159.8%
FY22 Q4 -29.7%
FY23 Q4 -305.0%
FY24 Q4 -432.8%
FY25 Q4 -401.1%

Data: SEC EDGAR XBRL company facts (as filed in 10-K/10-Q); forms 20-F, 20-F/A. Generated November 3, 2026. Definitions in our methodology.

Financial statements

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Nano Labs Ltd: annual financial statements
Fiscal year 2020 Dec 2020 2021 Dec 2021 2022 Dec 2022 2023 Dec 2023 2024 Dec 2024 2025 Dec 2025
Income
Revenue 0 6 146 11 6 4
Gross profit 0 −1 34 −15 2 −6
EBITDA −5 −27 4 −36 −15 11
Operating income −5 −28 3 −37 −16 10
Net income −5 −27 5 −36 −16 19
Diluted EPS −$0.70 −$6.03 $0.87 −$6.07 −$1.95 $0.95
Growth (year on year)
Revenue — +>999% +>999% −92.4% −49.0% −33.4%
EBITDA — — — <−999% — —
Operating income — — — <−999% — —
Net income — — — −871.0% — —
Diluted EPS — — — −797.8% — —
Margins
Gross margin 40.3% −10.4% 23.4% −132.1% 28.6% −147.3%
EBITDA margin <−999% −446.7% 2.5% −327.3% −257.7% 304.9%
Operating margin <−999% −453.3% 2.1% −332.9% −281.4% 264.4%
Net margin <−999% −443.6% 3.2% −322.7% −278.8% 501.6%
Free-cash-flow margin −186.4% 159.8% −29.7% −305.0% −432.8% −401.1%
Cash flow
Cash from operations −0 11 −41 −19 −19 −15
Capital spending 0 1 3 15 5 0
Free cash flow −1 10 −44 −34 −24 −15
Stock-based pay 0 0 1 0 0 0
Free cash flow after stock pay −1 10 −45 −34 −24 −15
Balance sheet
Cash 5 37 13 7 4 1
Total debt 0 0 2 20 27 32
Net debt (negative = net cash) −5 −37 −10 13 22 30
Diluted shares 8m 4m 5m 6m 8m 20m
Returned to shareholders
Buybacks — — — — — 0
Total returned — — — — — 0

Source: SEC EDGAR XBRL company facts (US and foreign periodic filings); column headings link to the filing. EBITDA is operating income plus depreciation and amortisation. Free cash flow is cash from operations minus capital spending. Growth is left blank when last year's figure was a loss or under 2% of revenue. Share counts and EPS are restated for stock splits. A dash means the company didn't report the figure.

Financial health

3 of 6 checks passed · December 31, 2025
What it owns · $160m
Short-term assets $62mLonger-term assets $98m
What it owes, and who funded it · $161m
Short-term liabilities $29mLonger-term liabilities $25mShareholders' equity $107m
  • Short-term assets cover short-term liabilities $62m of assets due within a year against $29m of liabilities due within a year.
  • Short-term assets cover long-term liabilities $62m short-term assets against $25m of longer-dated liabilities.
  • More cash than debt $1m of cash against $25m of debt.
  • Debt below 40% of shareholders' equity Debt is 24% of equity.
  • Debt burden no higher than five years ago Five-year comparison not available. Not assessable.
  • A year's operating cash flow covers at least 20% of debt −$15m of operating cash flow against $25m of debt.
  • Operating profit covers interest at least five times over Operating income of $10m against $2m of interest.

From Nano Labs Ltd's latest balance sheet as filed. Checks are fixed, documented rules (methodology), counted only where the company reports the figures — a dot means the filing doesn't break the item out. Descriptions of reported data, not advice.

Dividends, buybacks and capital spending

FY2025 Q4 TTM
Buybacks (TTM)
$231,939
Returned to shareholders
-2%
of free cash flow
Diluted share count
+146.7%
year over year
Total shareholder yield
0.8%
dividends 0.0% + buybacks 0.8% of market value
R&D spending
29.8%
of revenue
Days sales outstanding
4 days
receivables vs revenue

Competitors: side by side with peers

Closest by revenue in semiconductors
Growth, margins and cash generation against peers
Last 12 months unless stated NA GCTS ALMU MOBX PRSO ARBE Median
Revenue, last 12 months $4m $4m $4m $6m $8m $1m $1.1bn
Revenue growth, last 12 months −33.4% −32.8% −4.4% −49.8% −38.5% 33.6% 13.7%
Revenue growth, latest quarter — −17.9% −55.8% −66.4% −41.1% — 20.1%
Gross margin −147.3% −38.3% 35.2% 33.0% 56.6% −78.2% 48.1%
Operating margin 264.4% −852.0% −168.8% −533.8% −85.8% <−999% 5.0%
Operating margin, 3-year average — −461.4% −222.1% −605.7% −94.4% — 4.8%
Net margin 501.6% <−999% −205.3% −879.3% −85.6% <−999% 5.3%
Cash from operations / revenue −400.9% −933.3% −73.2% 18.0% −77.9% <−999% 17.1%
Free-cash-flow margin −401.1% −996.8% −87.7% 18.0% −82.0% <−999% 9.2%
Free-cash-flow margin, 3-year average — — −175.6% — −122.5% — 8.5%
Stock pay / revenue 0.3% 149.4% 101.3% 277.5% 6.8% 891.0% 5.6%
Change in share count 146.7% 36.2% 0.4% 93.5% — 37.6% 0.9%

Median of all 76 companies we cover in semiconductors. Shaded: best of the six on that line (lowest for stock pay and share-count growth). 3-year figures average the last three 12-month periods; 3-year growth is compound annual. Source: SEC filings.

Reported value
$10.5M
Institutions reporting
11
Shares held vs prior quarter
▼ 6.5%
Positions opened / closed
5 / 3

Top buyers and sellers, Q2 2026: 8 institutions bought and 3 sold ; the biggest buyer was Susquehanna International Group, LLP (+26K shares) and the biggest seller Mirae Asset Global Etfs Holdings Ltd (−396K). See which funds bought and sold →

Largest reported holders, June 30, 2026
Manager Value Shares Share of 13F value Shares QoQ
Smartleaf Asset Management LLC $10.4M 5.7M 98.7% 0.0%
Susquehanna International Group, LLP $48,052 26K 0.5% New
Jane Street Group, LLC $38,173 21K 0.4% ▲ 5.0%
Two Sigma Securities, LLC $26,749 14K 0.3% ▲ 10.4%
UBS Group AG $21,016 11K 0.2% ▲ 0.6%
Simplex Trading, LLC $1,113 1K 0.0% New
Jones Financial Companies LLLP $516 0K 0.0% New
Rhumbline Advisers $173 0K 0.0% 0.0%
Group One Trading LLC $81 0K 0.0% New
BNP Paribas Financial Markets $18 0K 0.0% 0.0%
Caitong International Asset Management Co., Ltd $11 0K 0.0% New

From Form 13F filings with the SEC ( quarterly data sets), as reported by each manager for June 30, 2026 and filed up to 45 days later. 13F reports cover long US-listed positions of managers above $100M only, so this is not Nano Labs Ltd's complete shareholder register. Values are as reported by the filers .

Insider trading activity

Full insider history and chart
Recent insider open-market transactions
Insider Date Trade Shares Price Value
Hu Nan Director September 1, 2026 Sell 3,000 $2.25 $6,750
Hu Nan Director September 1, 2026 Sell 3,165 $2.22 $7,026
Hu Nan Director September 1, 2026 Sell 1,000 $2.31 $2,310
Hu Nan Director September 1, 2026 Sell 1,000 $2.25 $2,250
Hu Nan Director April 28, 2026 Sell 23 $2.01 $46
Hu Nan Director April 28, 2026 Sell 46 $2.01 $92
Hu Nan Director April 28, 2026 Sell 48 $2.01 $96
Hu Nan Director April 28, 2026 Sell 54 $2.01 $109
Hu Nan Director April 28, 2026 Sell 200 $2.01 $402
Hu Nan Director April 28, 2026 Sell 30 $2.01 $60
Hu Nan Director April 28, 2026 Sell 208 $2.01 $418
Hu Nan Director April 28, 2026 Sell 400 $2.01 $804

From insiders' Form 4 filings with the SEC. Excludes awards, option exercises and shares withheld for tax. "Pre-set plan" means the filing marks the trade as made under a Rule 10b5-1 plan. See every insider trade since five years ago, on a price chart.

Earnings dates and SEC filings

Results announcements

Recent SEC filings

Data status

When each part of this page on Nano Labs Ltd was last updated.

DataLast updatedSource
Share priceExchange closing prices
News and updatesCompany releases and SEC 8-K filings
Analyst estimatesAggregated analyst estimates
Valuation and scoresOur models, from the filed figures

How we build and check these figures: methodology and data sources.

Nano Labs Ltd in brief

What does Nano Labs Ltd do?
Nano Labs Ltd is a US-listed company in the semiconductors industry. Its financial year ends in December.
What is Nano Labs Ltd's stock ticker?
Nano Labs Ltd trades under the ticker NA on Nasdaq. This page brings together its financial statements, valuation models, ownership and recent company updates.
What is Nano Labs Ltd's revenue, and how fast is it growing?
Over its most recent trailing twelve months, Nano Labs Ltd reported revenue of $3.8M, 33.4% lower than a year earlier, according to its SEC filings.
What is Nano Labs Ltd's free cash flow?
Nano Labs Ltd's free-cash-flow margin is -401.1% of revenue over the trailing twelve months.
Who are Nano Labs Ltd's largest institutional shareholders?
By value reported in 13F filings for June 30, 2026, the largest reported holders are Smartleaf Asset Management LLC, Susquehanna International Group, LLP and Jane Street Group, LLC. 13F reports cover long US-listed positions of managers above $100M, filed up to 45 days after quarter end.
Is Nano Labs Ltd buying back stock, and does it pay a dividend?
Nano Labs Ltd spent $231,939 on share repurchases over the trailing twelve months, and its diluted share count still rose 146.7% over the year.
How much debt does Nano Labs Ltd have?
Nano Labs Ltd's debt-to-equity ratio is 23.8%, from its latest balance sheet. The financial health section below sets out its other solvency checks.
Who are Nano Labs Ltd's competitors?
In our Semiconductors peer group, the companies closest to Nano Labs Ltd are GCT Semiconductor Holding, Inc., Aeluma, Inc., Mobix Labs, Inc, Peraso Inc. and Arbe Robotics Ltd. The side-by-side comparison below sets their revenue, margins and growth against Nano Labs Ltd's.
Are insiders buying or selling Nano Labs Ltd stock?
Over the last 12 months, Nano Labs Ltd's directors and officers reported 0 open-market purchases and 91 sales on Form 4. The insider trading page charts every trade.